Perth, Australia, January 18, 2017 (ABN Newswire) - 
MMJ PhytoTech Limited (
ASX:MMJ) (“MMJ” or “the Company”) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) (“Harvest One”) has launched a C$15 million private placement (“the placement”) to finalise the acquisition of the Company’s cannabis subsidiaries United Greeneries Holdings Ltd (“UG”) and Satipharm AG (“Satipharm”) respectively.
The placement follows the signing of a definitive agreement by both parties on 8th December 2016, which outlined the sale of 100% of the issued and outstanding shares of UG and Satipharm to Harvest One.
A full copy of the announcement released by Harvest One to the Toronto Venture Exchange outlining further details of the placement and the transaction can be viewed in the following link below.
To view tables and figures, please visit:
http://abnnewswire.net/lnk/07LID47L
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
